AstraZeneca (AZN)

Sector:

Pharma and Biotech

Index:

FTSE 100

10,492.00p
   
  • Change Today:
      74.00p
  • 52 Week High: 13,276.00
  • 52 Week Low: 9,667.00
  • Currency: UK Pounds
  • Shares Issued: 1,550.64m
  • Volume: 143,023
  • Market Cap: £162,693m
  • RiskGrade: 123
  • Beta: 0.00

Latest ShareCast News

London close: Stocks finish choppy week in the black

By Josh White

Date: Friday 16 May 2025

(Sharecast News) - London equities ended the week higher on Friday, supported by gains in pharmaceutical and energy stocks.

AstraZeneca ShareCast News

London close: Stocks rally on US-China tariff deal 12-May-2025 ShareCast
Pharma stocks slide as Trump threatens price cut... 12-May-2025 ShareCast
Sunday newspaper round-up: US-China, Aerospace, ... 11-May-2025 ShareCast
London close: FTSE snaps 16-day win streak ahead... 07-May-2025 ShareCast
GSK, AstraZeneca slide after FDA unveils new vac... 07-May-2025 ShareCast

AstraZeneca Regulatory News

Acquisition of EsoBiotec completed 20-May-2025 07:00 RNS
Imfinzi improved DFS in early bladder cancer 09-May-2025 07:00 RNS
Enhertu improved pCR in early-stage breast cancer 07-May-2025 07:30 RNS
Calquence combination approved in EU for 1L MCL 06-May-2025 07:00 RNS
Breztri met primary endpoints in Ph3 asthma trials 02-May-2025 07:00 RNS

AstraZeneca Newspaper Links

GSK and AstraZeneca take hit as Trump vows to ma... 12-May-2025 Times
Fighting Frenchman shows us how as he ensures As... 30-Dec-2014 Daily Mail
Exclusive: UK firms vie for share of £170bn in A... 08-Dec-2014 The Independent
MARKET REPORT: Ariad on the up amid growing spec... 04-Dec-2014 Daily Mail
Some reasons why Pfizer won’t bid for AstraZenec... 19-Nov-2014 Guardian

AstraZeneca Tips & Analysis

Questor :AstraZeneca 29-Apr-2014 Telegraph
Questor : AstraZeneca 24-Jan-2014 Telegraph
Questor:AstraZeneca 22-Dec-2011 Telegraph
Investment Column:AstraZeneca 28-Oct-2011 The Independent
Investment Column: AstraZeneca 23-Jun-2011 The Independent

AstraZeneca News Wires

MedImmune Announces Zook as President 13-Nov-2008 PR Newswire
Survey Shows Lung Cancer Patients Blamed for The... 12-Nov-2008 PR Newswire
CRESTOR Demonstrates Dramatic CV Risk Reduction ... 09-Nov-2008 PR Newswire

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AstraZeneca Market Data

Currency UK Pounds
Share Price 10,492.00p
Change Today 74.00p
% Change 0.71 %
52 Week High 13,276.00
52 Week Low 9,667.00
Volume 143,023
Shares Issued 1,550.64m
Market Cap £162,693m
Beta 0.00
RiskGrade 123

AstraZeneca Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
93.48% below the market average93.48% below the market average93.48% below the market average93.48% below the market average93.48% below the market average
87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average87.23% below the sector average
Price Trend
11.22% below the market average11.22% below the market average11.22% below the market average11.22% below the market average11.22% below the market average
31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average31.91% above the sector average
Income
60.44% below the market average60.44% below the market average60.44% below the market average60.44% below the market average60.44% below the market average
14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average14.29% below the sector average
Growth
86.25% above the market average86.25% above the market average86.25% above the market average86.25% above the market average86.25% above the market average
100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average100.00% above the sector average

What The Brokers Say

Strong Buy 10
Buy 14
Neutral 5
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

AstraZeneca Dividends

  Latest Previous
  2nd Interim 1st Interim
Ex-Div 20-Feb-25 08-Aug-24
Paid 24-Mar-25 09-Sep-24
Amount 210.00¢ 100.00¢

Trades for 21-May-2025

Time Volume / Share Price
09:27 61 @ 10,492.00p
09:27 10 @ 10,492.00p
09:27 44 @ 10,492.00p
09:27 71 @ 10,492.00p
09:27 49 @ 10,492.00p

AstraZeneca Key Personnel

Chair Michel Demare

Top of Page